These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16897584)
1. Effect of pepstatin A on the virulence factors of Candida albicans strains isolated from vaginal environment of patients in three different clinical conditions. Consolaro ME; Gasparetto A; Svidzinski TI; Peralta RM Mycopathologia; 2006 Aug; 162(2):75-82. PubMed ID: 16897584 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis. Lian CH; Liu WD Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358 [TBL] [Abstract][Full Text] [Related]
3. Yeast vaginitis during pregnancy: susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Kalkanci A; Güzel AB; Khalil II; Aydin M; Ilkit M; Kuştimur S Med Mycol; 2012 Aug; 50(6):585-93. PubMed ID: 22369624 [TBL] [Abstract][Full Text] [Related]
4. Characterization of virulence factors of vaginal and anal isolates of Candida albicans sequentially obtained from patients with vulvovaginal candidiasis in north-east Brazil. Araújo Paulo de Medeiros M; Vieira de Melo AP; Maia de Sousa AM; Silva-Rocha WP; Pipolo Milan E; Maranhão Chaves G J Mycol Med; 2017 Dec; 27(4):567-572. PubMed ID: 28844452 [TBL] [Abstract][Full Text] [Related]
5. Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. Watts HJ; Cheah FS; Hube B; Sanglard D; Gow NA FEMS Microbiol Lett; 1998 Feb; 159(1):129-35. PubMed ID: 9485603 [TBL] [Abstract][Full Text] [Related]
6. Candida and its dual lifestyle as a commensal and a pathogen. Cauchie M; Desmet S; Lagrou K Res Microbiol; 2017; 168(9-10):802-810. PubMed ID: 28263903 [TBL] [Abstract][Full Text] [Related]
7. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice. Shao MK; Qi WJ; Hou MY; Luo DD J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814 [TBL] [Abstract][Full Text] [Related]
8. Correlation between antifungal resistance and virulence factors in Candida albicans recovered from vaginal specimens. El-Houssaini HH; Elnabawy OM; Nasser HA; Elkhatib WF Microb Pathog; 2019 Mar; 128():13-19. PubMed ID: 30562603 [TBL] [Abstract][Full Text] [Related]
9. Quercetin Assists Fluconazole to Inhibit Biofilm Formations of Fluconazole-Resistant Candida Albicans in In Vitro and In Vivo Antifungal Managements of Vulvovaginal Candidiasis. Gao M; Wang H; Zhu L Cell Physiol Biochem; 2016; 40(3-4):727-742. PubMed ID: 27915337 [TBL] [Abstract][Full Text] [Related]
10. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Korting HC; Schaller M; Eder G; Hamm G; Böhmer U; Hube B Antimicrob Agents Chemother; 1999 Aug; 43(8):2038-42. PubMed ID: 10428932 [TBL] [Abstract][Full Text] [Related]
12. Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Schaller M; Korting HC; Borelli C; Hamm G; Hube B Infect Immun; 2005 May; 73(5):2758-65. PubMed ID: 15845479 [TBL] [Abstract][Full Text] [Related]
13. Effect of progesterone on Candida albicans vaginal pathogenicity. Alves CT; Silva S; Pereira L; Williams DW; Azeredo J; Henriques M Int J Med Microbiol; 2014 Nov; 304(8):1011-7. PubMed ID: 25183575 [TBL] [Abstract][Full Text] [Related]
14. Evidence for a role for secreted aspartate proteinase of Candida albicans in vulvovaginal candidiasis. De Bernardis F; Agatensi L; Ross IK; Emerson GW; Lorenzini R; Sullivan PA; Cassone A J Infect Dis; 1990 Jun; 161(6):1276-83. PubMed ID: 2189009 [TBL] [Abstract][Full Text] [Related]
15. The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium. Schaller M; Bein M; Korting HC; Baur S; Hamm G; Monod M; Beinhauer S; Hube B Infect Immun; 2003 Jun; 71(6):3227-34. PubMed ID: 12761103 [TBL] [Abstract][Full Text] [Related]
16. Identification of inhibitors of drug-resistant Candida albicans strains from a library of bicyclic peptidomimetic compounds. Trabocchi A; Mannino C; Machetti F; De Bernardis F; Arancia S; Cauda R; Cassone A; Guarna A J Med Chem; 2010 Mar; 53(6):2502-9. PubMed ID: 20184325 [TBL] [Abstract][Full Text] [Related]
17. Different expression levels of Bonfim-Mendonça PS; Tobaldini-Valério FK; Capoci IR; Faria DR; Sakita KM; Arita GS; Negri M; Kioshima ÉS; Svidzinski TI Future Microbiol; 2021 Mar; 16():211-219. PubMed ID: 33595345 [No Abstract] [Full Text] [Related]
18. Contribution of Aspartic Proteases in Candida Virulence. Protease Inhibitors against Candida Infections. Monika S; Małgorzata B; Zbigniew O Curr Protein Pept Sci; 2017; 18(10):1050-1062. PubMed ID: 27514853 [TBL] [Abstract][Full Text] [Related]
19. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance. Li X; Chen S; Lyu X; Tian J Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans. Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]